Key statistics
On Tuesday, Santhera Pharmaceuticals Holding AG (SANN:SWX) closed at 12.58, -29.17% below its 52-week high of 17.76, set on Feb 13, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.02 |
---|---|
High | 12.82 |
Low | 12.02 |
Bid | 11.96 |
Offer | 11.96 |
Previous close | 12.28 |
Average volume | 16.64k |
---|---|
Shares outstanding | 13.58m |
Free float | 9.98m |
P/E (TTM) | -- |
Market cap | 166.73m CHF |
EPS (TTM) | -3.68 CHF |
Data delayed at least 15 minutes, as of Jul 15 2025 16:31 BST.
More ▼
- Santheras Aktionäre stimmen an der heutigen Generalversammlung allen Anträgen des Verwaltungsrats zu
- Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting
- Gesamtjahresergebnisse für das am 31. Dezember 2024 endende Jahr
- Santhera Full Year Results for the Year Ended 31 December 2024
- Santhera veröffentlicht Einladung zur ordentlichen Generalversammlung
- Santhera Publishes Agenda for its Annual General Meeting
- Santhera informiert über den kommerziellen Rollout von AGAMREE®
- Santhera shares updates on commercial rollout of AGAMREE®
- Santhera schlägt Dr. Melanie Rolli als neues Mitglied des Verwaltungsrats vor
- Santhera proposes Dr. Melanie Rolli as new member of Board of Directors
More ▼